Description

Salofalk (mesalazine) gastroresistant granules 500 g. №50

Ingredients

Active ingredient: Mesalazine

Dosage

Recommended dosage: The usual dose is 1 to 4 grams daily, taken in divided doses.

Indications

Indicated for: Treatment of mild to moderate ulcerative colitis and maintenance of remission.

Contraindications

Do not use if: Allergic to mesalazine or salicylates; severe renal impairment; severe hepatic impairment.

Directions

Administration: Administer the granules orally, preferably after meals. Do not crush or chew the granules.

Scientific Evidence

Mesalazine, the active ingredient in Salofalk, has been extensively studied for its efficacy in treating ulcerative colitis. Research published in the Journal of Crohn’s and Colitis has shown that mesalazine is effective in inducing and maintaining remission in patients with ulcerative colitis.

Additional Information

It is important to follow the prescribed dosage and administration instructions to achieve the best results with Salofalk. Consult your healthcare provider for personalized advice and monitoring while using this medication.

Salofalk granules work by releasing mesalazine in the colon, where it exerts its anti-inflammatory effects locally. This targeted action helps reduce inflammation and symptoms associated with ulcerative colitis without significant systemic absorption.